NelsonA, ParkeS, MellingerU, et al.Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: Results from a clinical study conducted in North America. J Womens Health, 2014; 23:204–210.
2.
LidegaardØ, LøkkegaardE, SvendsenAL, AggerC. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ, 2009; 339:b2890.
WenzlR, BenninkHC, van BeekA, et al.Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol. Fertil Steril, 1993; 60:616–619.
5.
FruzzettiF, TremollieresF, BitzerJ. An overview of the development of combined oral contraceptives containing estradiol: Focus on estradiol valerate/dienogest. Gynecol Endocrinol, 2012; 28:400–408.
